A racist past and hotter future are testing Western water like never before

In just a few weeks, the highly anticipated second season of Korean television series "Squid Game" w

AI may be the hiring tool of the future, but it could come with the old relics of discrimination.

Lawyers for NPR News and The New York Times have jointly filed a legal brief asking a judge to unsea

So how do you get people to drink more soda? That's a question Coca-Cola and other soda makers are

A record number of Americans are 401(k) millionaires, thanks to a surging stock market. The tally of

Amidst a summer of fires, floods and heat waves, scientists on Monday delivered yet another reminder

A 25-year-old man has been taken into custody in connection with a shooting over the weekend in down

Men with melanoma, particularly Black men, are more likely to die than women with melanoma, accordin

It's been a season full of twists and turns, but the part one for "Survivor" Season 47 finale proved

M&M's spokescandies — the cartoon versions of the candies that appear in advertisements — will b

For the third time in less than a year, the operators of a new natural gas compressor shoe-horned in

We independently selected these products because we love them, and we think you might like them at t

The NFL playoff drive is hitting high gear, Week 15 marking the return to action of all 32 teams – w

So how do you get people to drink more soda? That's a question Coca-Cola and other soda makers are

After 20 years and $200 billion in revenue, Humira — an injectable treatment for rheumatoid arthriti

AbbVie's blockbuster drug Humira finally loses its 20-year, $200 billion monopoly